Skip to main content

Advertisement

SpringerLink
Log in

Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

According to the current WHO classification of cardiomyopathies, myocarditis is an inflammatory disease of the myocardium and is diagnosed by endomyocardial biopsy using established histological, immunological and immunohistochemical criteria; it may be idiopathic, infectious or autoimmune and may heal or lead to dilated cardiomyopathy (DCM). DCM is characterized by dilatation and impaired contraction of the left or both ventricles; it may be idiopathic, familial/genetic, viral and/or immune. The diagnosis of DCM requires exclusion of known, specific causes of heart failure, including coronary artery disease. On endomyocardial biopsy, there is myocyte loss, compensatory hypertrophy, fibrous tissue and immunohistochemical findings consistent with chronic inflammation (myocarditis) in 30–40 % of cases. In a patient subset, myocarditis and DCM represent the acute and chronic stages of an inflammatory disease of the myocardium, which can be viral, post-infectious immune or primarily organ-specific autoimmune. Here, we review the clinical presentation, etiopathogenetic diagnostic criteria, and management of immune-mediated and autoimmune myocarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Richardson P, McKenna WJ, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841–842

    PubMed  CAS  Google Scholar 

  2. Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. Lancet 375:752–762

    PubMed  Google Scholar 

  3. Aretz HT, Billingham ME, Edwards WE, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ (1985) Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1:1–10

    Google Scholar 

  4. Magnani JW, Dec WG (2006) Myocarditis. Current trends in diagnosis and treatment. Circulation 113:876–890

    PubMed  Google Scholar 

  5. Angelini A, Crosato M, Boffa GM, Calabrese F, Calzolari V, Chioin R, Daliento L, Thiene G (2002) Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart 87:210–215

    PubMed  CAS  Google Scholar 

  6. Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, Thiene G (2000) Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84:245–250

    PubMed  CAS  Google Scholar 

  7. Maisch B, Herzum M, Hufnagel G, Schonian U (1996) Immunosuppressive and immunomodulatory treatment for myocarditis. Curr Opin Cardiol 11:310–324

    PubMed  CAS  Google Scholar 

  8. Yajima T, Knowlton KU (2009) Viral myocarditis: from the perspective of the virus. Circulation 119:2615–2624

    PubMed  Google Scholar 

  9. Calabrese F, Thiene G (2003) Myocarditis and inflammatory cardiomyopathy: microbiological and molecular aspects. Cardiovasc Pathol 60:11–25

    CAS  Google Scholar 

  10. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and etiopathogenetic features at diagnosis. Eur Heart J 28(11):1326–1333

    PubMed  Google Scholar 

  11. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109(10):1250–1258

    PubMed  Google Scholar 

  12. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362(13):1248–1249

    PubMed  CAS  Google Scholar 

  13. Liu P, Martino T, Opavsky MA, Penninger J (1996) Viral myocarditis: balance between viral infection and immune response. Can J Cardiol 12:935–943

    PubMed  CAS  Google Scholar 

  14. Cambridge G, MacArthur CG, Waterson AP, Goodwin JF, Oakley CM (1979) Antibodies to Coxsackieviruses in congestive cardiomyopathy. Br Heart J 41:692–696

    PubMed  CAS  Google Scholar 

  15. Baboonian C, Treasure T (1997) Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539–543

    PubMed  CAS  Google Scholar 

  16. Schultheiss HP, Kühl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32(21):2616–2625

    PubMed  Google Scholar 

  17. Maisch B, Schönian U, Crombach M, Wendl I, Bethge C, Herzum M, Klein HH (1993) Cytomegalovirus associated inflammatory heart muscle disease. Scan J Infect Dis 88:135–148

    CAS  Google Scholar 

  18. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang YH, Bodurtha J, Gelb B, Ni J (1994) Acute myocarditis, rapid diagnosis by PCR in children. Circulation 90:330–339

    PubMed  CAS  Google Scholar 

  19. Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C infection. Circulation 92:2225–2519

    Google Scholar 

  20. Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B (2003) Prevalence of Parvovirus B 19 genome in endomyocardial biopsy specimen. Hum Pathol 34:80–86

    Google Scholar 

  21. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High Prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893

    PubMed  Google Scholar 

  22. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970

    PubMed  Google Scholar 

  23. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472

    PubMed  Google Scholar 

  24. Magnani JW, Danik HJ, Dec GW, DiSalvo TG Jr (2006) Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathological, clinical, and hemodynamic predictors. Am Heart J 151:463–470

    PubMed  Google Scholar 

  25. Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, The Myocarditis Treatment Trial Investigators (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269–275

    PubMed  CAS  Google Scholar 

  26. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863

    PubMed  Google Scholar 

  27. Rose NR (2009) Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730–737

    PubMed  CAS  Google Scholar 

  28. Huber SA, Gauntt CJ, Sakkinen P (1999) Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res 51:35–68

    Google Scholar 

  29. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A. 1(89):314–318

    Google Scholar 

  30. MacLellan RW, Lusis AJ (2003) Dilated cardiomyopathy: learning to live with yourself. Nat Med 9:1455–1456

    PubMed  CAS  Google Scholar 

  31. Rose NR (2000) Viral damage or ‘molecular mimicry’: placing the blame in myocarditis. Nature Med 6:631–632

    PubMed  CAS  Google Scholar 

  32. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630–3636

    PubMed  CAS  Google Scholar 

  33. Smith SC, Allen PM (1991) Myosin-induced myocarditis is a T cell-mediated disease. J Immunol 147:2141–2147

    PubMed  CAS  Google Scholar 

  34. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234–8240

    PubMed  CAS  Google Scholar 

  35. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A (1994) Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75:278–284

    PubMed  CAS  Google Scholar 

  36. Taneja V, Behrens M, Cooper LT, Yamada S, Kita H, Redfield MM, Terzic A, David C (2007) Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol 42:1054–1064

    PubMed  CAS  Google Scholar 

  37. Elliott JF, Liu J, Yuan ZN, Bautista-Lopez N, Wallbank SL, Suzuki K, Rayner D, Nation P, Robertson MA, Liu G, Kavanagh KM (2003) Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci USA 100:13447–13452

    PubMed  CAS  Google Scholar 

  38. Satoh M, Shimoda Y, Maesawa C, Akatsu T, Ishikawa Y, Minami Y, Hiramori K, Nakamura M (2006) MyD88 signaling controls autoimmune myocarditis induction. Circulation 113:258–265

    Google Scholar 

  39. Lv H, Havari E, Pinto S, Gottumukkala R, Cornivelli L,1 Raddassi K, Matsui T, Rosenzweig A, Bronson RT, Smith R, Fletcher AL, Turley SJ, Wucherpfennig K, Kyewski B, Lipes MA (2011) Impaired thymic tolerance to α-myosin directs autoimmunity to the heartin mice and humans. J Clin Invest 121:1561–1573

    Google Scholar 

  40. Guler ML, Ligons DL, Wang Y, Bianco M, Broman KW, Rose NR (2005) Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol 174:2167–2173

    PubMed  CAS  Google Scholar 

  41. Ono M, Shimizu J, Miyachi Y, Sakaguchi S (2006) Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein high, Foxp3-expressing CD25+ and CD25− regulatory T cells. J Immunol 176:4748–4756

    PubMed  CAS  Google Scholar 

  42. Caforio ALP, Tona F, Bottaro S, Vinci A, Daliento L, Thiene G, Iliceto S (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41(1):35–45

    PubMed  CAS  Google Scholar 

  43. Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344:773–777

    PubMed  CAS  Google Scholar 

  44. Caforio ALP, Mahon NG, Baig KM, Tona F, Murphy RT, Elliott PM, McKenna WJ (2007) Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115:76–83

    PubMed  Google Scholar 

  45. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkison DV (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 93:1189–1191

    PubMed  Google Scholar 

  46. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14:426–428

    PubMed  CAS  Google Scholar 

  47. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and shared controls. Nature 447:661–683

    Google Scholar 

  48. The International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:1–12

    Google Scholar 

  49. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E, Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Tîrgovişte C; Genetics of Type 1 Diabetes in Finland, Simmonds MJ, Heward JM, Gough SC, Wellcome Trust Case Control Consortium, Dunger DB, Wicker LS, Clayton DG (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 39: 857–864

    Google Scholar 

  50. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, Bourget K, Plagnol V, Field S, Atkinson M, Clayton DG, Wicker LS, Todd JA (2007) Large-scale genetic fine mapping and genotype-phenotype associations implicate a polymorphism in the IL2RA region in Type 1 diabetes. Nat Genet 39:1074–1082

    PubMed  CAS  Google Scholar 

  51. Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio AL, McKenna WJ, Falaschi A, Giacca M, Camerini F (1999) Familial dilated cardiomyopathy:evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 34:181–190

    PubMed  CAS  Google Scholar 

  52. Portig I, Wilke A, Freyland M, Wolf MJ, Richter A, Ruppert V, Pankuweit S, Maisch B (2006) Familial inflammatory dilated cardiomyopathy. Eur J Heart Fail 8:816–825

    PubMed  CAS  Google Scholar 

  53. Jin B, Ni H, Geshang Q, Li Y, Shen W, Shi H (2011) HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: A meta-analysis involving 11,761 subjects. Tissue Antigens 77:107–111

    PubMed  CAS  Google Scholar 

  54. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996) Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis? Circulation 94:983–991

    PubMed  CAS  Google Scholar 

  55. Frustaci A, Verardo R, Caldarulo M, Acconcia MC, Russo MA, Chimenti C (2007) Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J 28:733–740

    PubMed  Google Scholar 

  56. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA (2005) Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112:3680–3687

    PubMed  Google Scholar 

  57. Mahon NG, Madden B, Caforio ALP, Elliott PM, Haven AJ, Keogh BE, Davies MJ, McKenna WJ (2002) Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 39:455–462

    PubMed  Google Scholar 

  58. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 104:39–45

    PubMed  CAS  Google Scholar 

  59. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648

    PubMed  Google Scholar 

  60. Okazaki T, Honjo T (2005) Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Trends Mol Med 11:322–326

    PubMed  CAS  Google Scholar 

  61. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW, Giant Cell Myocarditis Treatment Trial Investigators (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102(11):1535–1539

    PubMed  CAS  Google Scholar 

  62. Caforio ALP, Bonifacio E, Stewart JT et al (1990) Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 15:1527–1534

    PubMed  CAS  Google Scholar 

  63. Caforio ALP, Goldman JH, Haven AJ, Baig KM, Dalla Libera L, McKenna WJ (1997) Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J 18:270–275

    PubMed  CAS  Google Scholar 

  64. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of∝ and β cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734–1742

    PubMed  CAS  Google Scholar 

  65. Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP (2000) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35:11–18

    PubMed  CAS  Google Scholar 

  66. Warraich RS, Dunn MJ, Yacoub MH (1999) Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun 259:255–261

    PubMed  CAS  Google Scholar 

  67. Wallukat G, Morwinski M, Kowal K, Förster A, Boewer V, Wollenberger A (1991) Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 12(Suppl D): 178–181

    Google Scholar 

  68. Limas CJ, Limas C (1991) β-receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J 12(Suppl D): 175–177

    Google Scholar 

  69. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the β1-adrenoceptor with positive chronotropic effect. Circulation 89:2667–2760

    Google Scholar 

  70. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of β1-adrenoceptor activity by domain-specific antibodies and heart-failure associated autoantibodies. J Am Coll Cardiol 36:1280–1287

    PubMed  CAS  Google Scholar 

  71. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385–391

    PubMed  CAS  Google Scholar 

  72. Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106:2448–2453

    PubMed  CAS  Google Scholar 

  73. Caforio ALP, Wagner R, Gill JR, Bonifacio E, Bosi E, Miles A, McKenna WJ, Bottazzo GF (1991) Organ-specific cardiac autoantibodies: new serological markers for systemic hypertension in autoimmune polyendocrinopathy. Lancet 337:1111–1115

    PubMed  CAS  Google Scholar 

  74. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, Honjo T (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291:319–322

    PubMed  CAS  Google Scholar 

  75. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9:1477–1483

    PubMed  CAS  Google Scholar 

  76. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114:1693–1702

    PubMed  Google Scholar 

  77. Kaya Z, Göser S, Buss SJ, Leuschner F, Ottl R, Li J, Völkers M, Zittrich S, Pfitzer G, Rose NR, Katus HA (2008) Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 118:2063–2072

    PubMed  CAS  Google Scholar 

  78. Schultheiss HP, Kuhl U, Schwimmbeck P et al (1990) Biomolecular changes in dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer Verlag, Berlin, pp 221–234

    Google Scholar 

  79. Schultheiss HP, Ulrich G, Janda I, Melzner B, Ulrich G, Morad M (1988) Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 168:2105–2119

    PubMed  CAS  Google Scholar 

  80. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a β1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419–1429

    PubMed  CAS  Google Scholar 

  81. Liu J, Mao W, Iwai C, Fukuoka S, Vulapalli R, Huang H, Wang T, Sharma VK, Sheu SS, Fu M, Liang CS (2008) Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress. J Mol Cell Cardiol 44:304–314

    PubMed  Google Scholar 

  82. Omerovic E, Bollano E, Anderson B, Kujacic V, Waagstein F, Schulze W, Fu M (2000) Induction of cardiomyopathy in severe combined immunodeficiency mice by lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity 32:271–280

    PubMed  CAS  Google Scholar 

  83. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99(5):649–654

    PubMed  CAS  Google Scholar 

  84. Baba A, Yoshikawa T, Ogawa S (2002) Autoantibodies against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 40:1153–1159

    PubMed  CAS  Google Scholar 

  85. Klein R, Maisch B, Kochsiek K, Berg PA (1984) Demonstration of organ specific antibodies against heart mitichondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 58:283–292

    PubMed  CAS  Google Scholar 

  86. Ansari AA, Neckelmann N, Villinger F, Leung P, Danner DJ, Brar SS, Zhao S, Gravanis MB, Mayne A, Gershwin ME, Herskowitz A (1994) Epitope mapping of the branched chain α-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol 153:4754–4765

    PubMed  CAS  Google Scholar 

  87. Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, Hjalmarson A, Hoebeke J (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964–1968

    PubMed  CAS  Google Scholar 

  88. Fu LXM, Schulze W, Wallukat G, Hjalmarson Å, Hoebeke J (1996) A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin Immunol Immunopathol 78:203–207

    PubMed  CAS  Google Scholar 

  89. Jahns R, Schlipp A, Boivin V, Lohse MJ (2010) Targeting receptor-antibodies in immune-cardiomyopathy. Semin Thromb Hemost 36:212–218

    PubMed  CAS  Google Scholar 

  90. Götz M., Boivin V., Holthoff H.-P., Adler K., Lappo M., Truöl S., Degen H., Steiger N., Lohse M.J., Jahns R., Ungerer M. Administration of the cyclic peptide COR-1 in humans (phase I study). Ex vivo measurements of anti-beta1-receptor antibody neutralisation and of immune parameters (2012). Eur J Heart Fail 14:1230–1239

  91. Kuan AP, Zuckier L, Liao L, Factor SM, Diamond B (2000) Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice. Circ Res 86:281–285

    PubMed  CAS  Google Scholar 

  92. Mao W, Fukuoka S, Iwai C, Liu J, Sharma VK, Sheu SS, Fu M, Liang C (2007) Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine. Am J Physiol (Heart Circ Physiol) 293:H1636–H1645

    Google Scholar 

  93. Nikolaev VO, Boivin V, Störk S, Angermann CE, Ertl G, Lohse MJ, Jahns R (2007) A novel fluorescent method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50:423–431

    PubMed  CAS  Google Scholar 

  94. Mobini R, Staudt A, Felix SB, Baumann G, Wallukat G, Deinum J, Svensson H, Hjalmarson A, Fu M (2003) Hemodynamic improvement and removal of autoantibodies against the β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 20:345–350

    PubMed  CAS  Google Scholar 

  95. Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio ALP, Felix SB, Fu M, Katus H, Angermann CE, Lohse MJ, Ertl G, Störk S, Jahns R (2010) Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the etiology, titre-course, and survival (ETiCS) Study—on behalf of the ETiCS-Study Group. Eur J Heart Fail 12:753–762

    PubMed  CAS  Google Scholar 

  96. Caforio ALP, Goldman JH, Baig KM, Haven AJ, Dalla Libera L, Keeling PJ, McKenna WJ (1997) Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 77:62–67

    PubMed  CAS  Google Scholar 

  97. Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995–2002

    PubMed  CAS  Google Scholar 

  98. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646–652

    PubMed  CAS  Google Scholar 

  99. Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB (2008) Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Am Heart J 156:92–99

    PubMed  CAS  Google Scholar 

  100. Leuschner F, Li J, Göser S, Reinhardt L, Ottl R, Bride P, Zehelein J, Pfitzer G, Remppis A, Giannitsis E, Katus HA, Kaya Z (2008) Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 29:1949–1955

    PubMed  Google Scholar 

  101. Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, Keren G, George J (2007) Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 117:198–203

    PubMed  Google Scholar 

  102. Maisch B, Deeg P, Liebau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 52:1072–1078

    PubMed  CAS  Google Scholar 

  103. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 16:839–846

    PubMed  CAS  Google Scholar 

  104. Fletcher GF, Wenger NK (1968) Autoimmune studies in patients with primary myocardial disease. Circulation 37:1032–1035

    PubMed  CAS  Google Scholar 

  105. Kirsner AB, Hess EV, Fowler NO (1973) Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. Am Heart Journal 86:625–630

    CAS  Google Scholar 

  106. Borda ES, Sterin-Borda L (1996) Antiadrenergic and muscarinic receptor antibodies in Chagas’ cardiomyopathy. Int J Cardiol 54:149–156

    PubMed  CAS  Google Scholar 

  107. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U (2001) Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33:1515–1525

    PubMed  CAS  Google Scholar 

  108. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 37:418–424

    PubMed  CAS  Google Scholar 

  109. Matsui S, Fu ML, Shimizu M, Fukuoka T, Teraoka K, Takekoshi N, Murakami E, Hjalmarson A (1995) Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 21:85–88

    PubMed  CAS  Google Scholar 

  110. Matsui S, Fu M (1996) Characteristic distribution of circulating autoantibodies against G-protein coupled cardiovascular receptors in patients with idiopathic dilated and hypertrophic cardiomyopathy. Int J Cardiol 54:143–147

    PubMed  CAS  Google Scholar 

  111. Staudt Y, Mobini R, Fu M, Felix SB, Kühn JP, Staudt A (2003) Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 466:1–6

    PubMed  CAS  Google Scholar 

  112. Stavrakis S, Kem DC, Patterson E, Lozano P, Huang S, Szabo B, Cunningham MW, Lazzara R, Yu X (2011) Opposing cardiac effects of autoantibody activation of beta-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol 148:331–336

    PubMed  Google Scholar 

  113. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF (1995) Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27:397–406

    PubMed  CAS  Google Scholar 

  114. Zhang L, Hu D, Li J, Wu Y, Liu X, Yang X (2002) Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure. Chin Med J (Engl) 115:1127–1131

    CAS  Google Scholar 

  115. Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, Wallukat G, Hoebeke J (1995) High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 26:864–869

    PubMed  CAS  Google Scholar 

  116. Sterin-Borda L, Perez Leiros C, Wald M, Cremaschi G, Borda E (1988) Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas’ disease. Clin Exp Immunol 74:349–354

    PubMed  CAS  Google Scholar 

  117. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25:1108–1115

    PubMed  CAS  Google Scholar 

  118. Chiale PA, Ferrari I (2001) Autoantibodies in Chagas’ cardiomyopathy and arrhythmias. Autoimmunity 34:205–210

    PubMed  CAS  Google Scholar 

  119. Fu ML (1996) Characterization of anti-heart M2 muscarinic receptor antibodies–a combined clinical and experimental study. Mol Cell Biochem 163–164:343–347

    PubMed  Google Scholar 

  120. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29:43–51

    PubMed  Google Scholar 

  121. Wallukat G, Nissen E, Morwinski R, Müller J (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz. 25:261–266

    PubMed  CAS  Google Scholar 

  122. Staudt A, Herda LR, Trimpert C, Lubenow L, Landsberger M, Dörr M, Hummel A, Eckerle LG, Beug D, Müller C, Hoffmann W, Weitmann K, Klingel K, Kandolf R, Kroemer HK, Greinacher A, Felix SB (2010) Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy. Clin Pharmacol Ther 87:452–458

    PubMed  CAS  Google Scholar 

  123. Trimpert C, Herda LR, Eckerle LG, Pohle S, Müller C, Landsberger M, Felix SB, Staudt A (2010) Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 40:685–691

    PubMed  CAS  Google Scholar 

  124. Goldman JH, Keeling PJ, Warraich RS, Baig MK, Redwood SR, Dalla Libera L, Sanderson JE, Caforio ALP, McKenna WJ (1995) Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 74:598–603

    PubMed  CAS  Google Scholar 

  125. Warraich RS, Noutsias M, Kazak I, Seeberg B, Dunn MJ, Schultheiss HP, Yacoub MH, Kuhl U (2002) Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 143:1076–1084

    PubMed  CAS  Google Scholar 

  126. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH (1993) Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 22:1378–1384

    PubMed  CAS  Google Scholar 

  127. Wolff PG, Kuhl U, Schultheiss HP (1989) Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 117:1303–1309

    PubMed  CAS  Google Scholar 

  128. Portig I, Pankuweit S, Maisch B (1997) Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 29:2245–2251

    PubMed  CAS  Google Scholar 

  129. Schultheiss HP, Bolte HD (1985) Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17:603–617

    PubMed  CAS  Google Scholar 

  130. Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier–an autoantigen in myocarditis and dilated cardiomyopathy–impair cardiac function. Circulation 81:959–969

    PubMed  CAS  Google Scholar 

  131. Caforio ALP, Tona F, Vinci A, Calabrese F, Ramondo A, Cacciavillani L, Corbetti F, Leoni L, Thiene G, Iliceto S, Angelini A (2009) Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail 11:428–431

    PubMed  Google Scholar 

  132. Cooper LT, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866

    PubMed  Google Scholar 

  133. Caforio ALP, Brucato A, Doria A, Brambilla G, Vinci A, Ghirardello A, Bottaro S, Tona F, Betterle C, Daliento L, Thiene G, Iliceto S (2010) High frequency of circulating anti-heart and anti-intercalated disc autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96:779–784

    PubMed  CAS  Google Scholar 

  134. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R (2003) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:945–950

    PubMed  Google Scholar 

  135. Yilmaz A, Mahrholdt H, Athanasiadis A, Vogelsberg H, Meinhardt G, Voehringer M, Kispert EM, Deluigi C, Baccouche H, Spodarev E, Klingel K, Kandolf R, Sechtem U (2008) Coronary vasospasm as the underlying cause of chest pain in patients with PVB19 myocarditis. Heart 94:1456–1463

    PubMed  CAS  Google Scholar 

  136. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695

    PubMed  Google Scholar 

  137. Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398

    PubMed  CAS  Google Scholar 

  138. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, Nguyen C, Cohen A, Slama MS, Steg PG, Le Guludec D (2001) Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 37:786–792

    PubMed  CAS  Google Scholar 

  139. Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Bohm M (2011) Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail 13:398–405

    PubMed  Google Scholar 

  140. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232

    PubMed  CAS  Google Scholar 

  141. Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F, Camerini F (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–291

    PubMed  CAS  Google Scholar 

  142. O’Connell JB, Henkin RE, Robinson JA, Subramanian R, Scanlon PJ, Gunnar RM (1984) Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 70:58–62

    PubMed  Google Scholar 

  143. Dec GW, Palacios I, Yasuda T, Fallon JT, Khaw BA, Strauss HW, Haber E (1990) Antimyosin antibody cardiac imaging: Its role in the diagnosis of myocarditis. J Am Coll Cardiol 16:97–104

    PubMed  CAS  Google Scholar 

  144. Sherif HM, Saraste A, Nekolla SG, Weidl E, Reder S, Tapfer A, Rudelius M, Higuchi T, Botnar RM, Wester HJ, Schwaiger M (2012) Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J Nucl Med 53:318–323

    Google Scholar 

  145. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP (2011) Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 7(4):546–554

    PubMed  Google Scholar 

  146. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 53:1475–1487

    Google Scholar 

  147. Baccouche H, Mahrholdt H, Meinhardt G, Merher R, Voehringer M, Hill S, Klingel K, Kandolf R, Sechtem U, Yilmaz A (2009) Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 30:2869–2879

    PubMed  CAS  Google Scholar 

  148. Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822

    PubMed  Google Scholar 

  149. Aletras AH, Kellman P, Derbyshire JA, Arai AE (2008) ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med 59:229–235

    PubMed  Google Scholar 

  150. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R (1998) Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97:1802–1809

    PubMed  CAS  Google Scholar 

  151. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R, Noutsias M, Schultheiss HP, Kühl U (2008) Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246:401–409

    PubMed  Google Scholar 

  152. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, d’Amati G, Edwards WD, Fallon JT, Fishbein MC, Gallagher PJ, Halushka MK, McManus B, Pucci A, Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C, Thiene G, van der Wal AC, Winters GL (2011). 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol doi:10.1016/j.carpath.2011.10.001

  153. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50:1914–1931

    PubMed  Google Scholar 

  154. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, Hill S, Mahrholdt H, Voehringer M, Schieber M, Klingel K, Kandolf R, Böhm M, Sechtem U (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 122:900–909

    PubMed  Google Scholar 

  155. Holzmann M, Nicko A, Kühl U, Noutsias M, Poller W, Hoffmann W, Morguet A, Witzenbichler B, Tschöpe C, Schultheiss HP, Pauschinger M (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118:1722–1728

    PubMed  Google Scholar 

  156. Warraich RS, Griffiths E, Falconar A, Pabbathi V, Bell C, Angelini G, Suleiman MS, Yacoub MH (2006) Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship. FASEB J 20:651–660

    PubMed  CAS  Google Scholar 

  157. Beavo JA, Brunton LL (2002) Epac-a directly cAMP-activated exchange protein. Nat Rev Mol Cell Biol 3:710–718

    PubMed  CAS  Google Scholar 

  158. Staudt A, Staudt Y, Dörr M, Böhm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke K-D, Baumann G, Felix SB (2004) Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44:829–836

    PubMed  Google Scholar 

  159. Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49:1684–1692

    PubMed  CAS  Google Scholar 

  160. Jahns R (2010) Autoantibodies directed against cardiac troponin I: Friend or Foe? (Editorial) Eur. J. Heart Fail 12:645–648

    CAS  Google Scholar 

  161. Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R (2006) Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152:697–704

    PubMed  Google Scholar 

  162. Galazka A (2000) The changing epidemiology of diphteria in the vaccine era. J Infect Dis 181(suppl 1):S2–S9

    PubMed  Google Scholar 

  163. Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC (2009) Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics 123(5):e835–e841

    PubMed  Google Scholar 

  164. Rassi A Jr, Rassi A, Marin-Neto JA (2009) Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104(Suppl 1):152–158

    PubMed  Google Scholar 

  165. Marin-Neto JA, Cuhna-Neto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109–1123

    PubMed  Google Scholar 

  166. Derouin F, Pelloux H, ESCMID Study Group on Clinical Parasitology (2008) Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 14(12):1089–1101

    Google Scholar 

  167. Sahasrabudhe NS, Jadhav MV, Deshmukh SD, Holla VV (2003) Pathology of Toxoplasma myocarditis in acquired immunodeficiency syndrome. Indian J Pathol Microbiol 46(4):649–651

    PubMed  Google Scholar 

  168. Cox JN, di Dió F, Pizzolato GP, Lerch R, Pochon N (1990) Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature. Virchows Arch A Pathol Anat Histopathol 417:255–259

    PubMed  CAS  Google Scholar 

  169. Puljiz I, Beus A, Kuzman I, Seiwerth S (2005) Electrocardiographic changes and myocarditis in trichinellosis: a retrospective study of 154 patients. Ann Trop Med Parasitol 99:403–411

    PubMed  CAS  Google Scholar 

  170. Rosenstein ED, Zucker MJ, Kramer N (2000) Giant cell myocarditis: most fatal of autoimmune diseases. Semin Arthritis Rheum 30(1):1–16

    PubMed  CAS  Google Scholar 

  171. Apte M, McGwin G Jr, Vilá LM, Kaslow RA, Alarcón GS, Reveille JD, LUMINA Study Group (2008) Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). Rheumatology 47(3):362–367

    Google Scholar 

  172. Hornberger LK, Al Rajaa N (2010) Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol 72(3):189–197

    PubMed  CAS  Google Scholar 

  173. Pulerwitz TC, Cappola TP, Felker GM, Hare JM, Baughman KL, Kasper EK (2004) Mortality in primary and secondary myocarditis. Am Heart J 147(4):746–750

    PubMed  Google Scholar 

  174. Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113(5):419–423

    PubMed  Google Scholar 

  175. Daniels PR, Berry GJ, Tazelaar HD, Cooper LT (2000) Giant cell myocarditis as a manifestation of drug hypersensitivity. Cardiovasc Pathol 9(5):287–291

    PubMed  CAS  Google Scholar 

  176. Ben m’rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L (2009). Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine 88(3):131–140

    Google Scholar 

  177. Mirabel M, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A, Chastre J, Combes A (2011) Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 39:1029–1035

    PubMed  Google Scholar 

  178. Chen YS, Wang MJ, Chou NK, Han YY, Chiu IS, Lin FY, Chu SH, Ko WJ (1999) Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg 68:2220–2224

    PubMed  CAS  Google Scholar 

  179. Hsu KH, Chi NH, Yu HY, Wang CH, Huang SC, Wang SS, Ko WJ, Chen YS (2011) Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center’s experience. Eur J Cardiothorac Surg. doi:10.1016/j.ejcts.2010.12.050

    Google Scholar 

  180. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Bohm M (2012) Update on myocarditis. J Am Coll Cardiol 59:779–792

    PubMed  Google Scholar 

  181. Basso C, Carturan E, Corrado D, Thiene G (2007) Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management and recommendations for sport activity. Cardiol Clin 25:423–429

    PubMed  Google Scholar 

  182. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carrè F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G, Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology, Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the european society of cardiology. Eur Heart J 26:1422–1445

    Google Scholar 

  183. Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74:182–188

    PubMed  CAS  Google Scholar 

  184. Krueger GR, Ablashi DV (2003) Human herpesvirus-6:a short review of its biological behaviour. Intervirology 46:257–269

    PubMed  Google Scholar 

  185. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793–2798

    PubMed  Google Scholar 

  186. Schultheiss HP (2008). The Effect of subcutaneous treatment with Interferon-Beta-1b Over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. Paper presented at: American Heart Association Scientific Sessions; November 11, 2008; New Orleans, LA

  187. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C, Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology (2006). Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 117(4 Suppl):S525–S553

    Google Scholar 

  188. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P (2001) Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103:220–225

    PubMed  CAS  Google Scholar 

  189. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:2254–2259

    PubMed  CAS  Google Scholar 

  190. Warren KG, Catz I, Ferenczi LZ, Krantz MJ (2006) Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. Eur J Neurol 13(8):887–895

    PubMed  CAS  Google Scholar 

  191. Tzartos SJ, Bitzopoulou K, Gavra I, Kordas G, Jacobson L, Kostelidou K, Lagoumintzis G, Lazos O, Poulas K, Sideris S, Sotiriadis A, Trakas N, Zisimopoulou P (2008) Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera. Ann NY Acad Sci 1132:291–299

    PubMed  Google Scholar 

  192. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J (1985) Goodpasture’s syndrome treated with staphylococcal protein A immunoadsorption. Lancet 2:1295–1296

    PubMed  CAS  Google Scholar 

  193. Palmer A, Gjorstrup P, Severn A, Welsh K, Taube D (1988) Treatment of systemic lupus erythematodes by extracorporeal immunoadsorption. Lancet 2:272

    PubMed  CAS  Google Scholar 

  194. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE (2008) The proteasome inhibitor borte-zemib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14:748–755

    PubMed  CAS  Google Scholar 

  195. Jahns R, Boivin V, Hein L, Palm D, Nikolaev VO, Müller J, Angermann CE, Ertl G, Lohse MJ (2005) A new cyclic receptor-peptide prevents development of heart dilatation and failure induced by antibodies activating cardiac beta1-adrenergic receptors. Circulation 112(suppl.II): 5–120)

    Google Scholar 

  196. Ungerer M, Boivin V, Holthoff HP, Adler K, Lohse MJ, Jahns R, Münch G (2010) First administration of COR-1 in man: a cyclic peptide which neutralizes anti-beta1-receptor antibodies in heart failure. Circulation 122(21, supplement): A 19730

    Google Scholar 

  197. Felix SB, Staudt A, Dörffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35(6):1590–1598

    PubMed  CAS  Google Scholar 

  198. Staudt A, Schaper F, Stangl V, Plagemann A, Böhm M, Merkel K, Wallukat G, Wernecke K-D, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681–2686

    PubMed  CAS  Google Scholar 

  199. Japanese Circulation Society (JCS) Joint Working group. Guidelines for diagnosis and treatment of myocarditis (2011). Circ J 75:734–743

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Cardiological, Thoracic and Vascular Sciences, Centro “V. Gallucci”, University of Padova-Policlinico, Via Giustiniani, 2, 35128, Padua, Italy

    Alida L. P. Caforio & S. Iliceto

  2. Haematology and Clinical Immunology, Department of Medicine, University of Padua, Padua, Italy

    Renzo Marcolongo

  3. Comprehensive Heart Failure Center (CFHC), University Hospital Würzburg, Würzburg, Germany

    Roland Jahns

  4. Department of Medicine, Heart Failure Unit, Sahlgrenska University Hospital, University of Göteborg, Göteborg, Sweden

    Michael Fu

  5. Klinik Fur Innere Medizin B, University of Greifswald, Greifswald, Germany

    Stephan B. Felix

Authors
  1. Alida L. P. Caforio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renzo Marcolongo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Jahns
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephan B. Felix
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Iliceto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alida L. P. Caforio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caforio, A.L.P., Marcolongo, R., Jahns, R. et al. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev 18, 715–732 (2013). https://doi.org/10.1007/s10741-012-9364-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-012-9364-5

Keywords

Search

Navigation